摘要
酪氨酸激酶抑制剂吉非替尼是近年来靶向抗肿瘤药物研究的热点。吉非替尼临床治疗作用明显、应用广泛为临床治疗肿瘤提供了更多的选择。本研究基于广东省专利大数据应用服务系统,运用专利情报分析理论,对重磅炸弹药品吉非替尼相关技术发展趋势、国内专利申请状况和国内外上市情况进行了梳理,在此基础上为国内仿制药机构和企业对于吉非替尼期开发、专利保护策略以及知识产权布局等战略决策提供一定的参考和建议。
Gefitinib, a tyrosine kinase inhibitor, has been a hot topic in recent years. Gefitinib has obviously clinical therapeutic effect and wide application, which provides more choices for clinical treatment of tumors.This study analyzed the related technology development trend, the domestic patent application situation and abroad listing of blockbuster drug Gefitinib based on the data of Guangdong Province patent application service system and the patent information analysis theory. On the basis of analysis , this study also provided references and recommendations to domestic generic institutions and enterprises for the research and development, the patent protection of intellectual property strategy and layout strategy of Gefitinib.
出处
《情报工程》
2017年第6期62-70,共9页
Technology Intelligence Engineering
基金
广东省医学科研技术研究基金青年项目"新药仿制过程中的机会识别与应用研究"(B2015065)
广东省教育厅青年创新人才项目"专利悬崖期重磅新药仿制的情报分析"(2015KQNCX058)
广东药科大学"创新强校"项目(2015CXQX173)的资助
关键词
吉非替尼
竞争态势
专利技术
情报分析
Gefitinib, competition situation, patent technology, patent analysis, intelligence analysis
